Published in
Elsevier, Respiratory Medicine, (176), p. 106274, 2021
DOI: 10.1016/j.rmed.2020.106274
Links
Tools
A new formulation of fluticasone propionate/salmeterol in a metered-dose inhaler (MDI HFA) allows for the reduction of a daily dose of corticosteroid and provides optimal asthma control - A randomized, multi-center, non-inferiority, phase IV clinical study
Journal article published in 2021 by
Maciej Kupczyk 
,
Paweł Majak,
Piotr Kuna,
Beata Asankowicz-Bargiel,
Eliza Barańska,
Rafał Dobek,
Sławomir Garbicz,
Joanna Jerzyńska ,
Anna Latos,
Wojciech Machowiak,
Bernadetta Majorek-Olechowska,
Anna Olech-Cudzik,
Iwona Poziomkowska-Gęsicka,
Mirosława Rulewicz-Warniełło,
Anna Świderska
and other authors.
,
Paweł Majak,
Piotr Kuna,
Beata Asankowicz-Bargiel,
Eliza Barańska,
Rafał Dobek,
Sławomir Garbicz,
Joanna Jerzyńska ,
Anna Latos,
Wojciech Machowiak,
Bernadetta Majorek-Olechowska,
Anna Olech-Cudzik,
Iwona Poziomkowska-Gęsicka,
Mirosława Rulewicz-Warniełło,
Anna Świderska
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 